Jekyll and Hyde, the p53 protein, pleiotropics antagonisms and the thrifty aged hypothesis of senescence

Medical Hypotheses

Volumn 68, Issue 6, 2007, Pages 1371-1377

  Zafon, Carles ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P53;

AGED; AGING; APOPTOSIS; ARTICLE; CANCER PREVENTION; CELL CYCLE; DNA DAMAGE; DNA REPAIR; EVOLUTION; GENE; GENE MUTATION; HUMAN; NATURAL SELECTION; PLEIOTROPY; PRIORITY JOURNAL; SENESCENCE; TUMOR SUPPRESSOR GENE;

AGED; AGING; ANIMALS; APOPTOSIS; CELL AGING; GENES, TUMOR SUPPRESSOR; HUMANS; MODELS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33947669479     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.10.043     Document Type: Article

References (60)

1. Williams G.C. Pleiotropy, natural selection, and the evolution of senescence. Evolution 11 (1957) 398-411
2. Clark W. Reflections on an unsolved problem of biology: the evolution of senescence and death. Adv Gerontol 14 (2004) 7-20
3. Campisi J. Aging, tumor suppression and cancer: high wire-act!. Mech Ageing Dev 126 (2005) 51-58
4. Cooper V., Bennett A., and Lenski R. Evolution of thermal dependence of growth rate of Escherichia coli populations during 20,000 generations in a constant environment. Evol Int J Org Evol 55 (2001) 889-896
5. Rauser C., Tierney J., Gunion S., Covarrubias G., Mueller L., and Rose M. Evolution of late-life fecundity in Drosophila melanogaster. J Evol Biol 19 (2006) 289-301
6. Reed D., and Bryant E. The evolution of senescence under curtailed life span in laboratory populations of Musca domestica (the houseflly). Heredity 85 (2000) 115-121
7. Snoke M., and Promislow D.E.L. Quantitative genetic tests of recent senescence theory: age-specific mortality and male fertility in Drosophila melanogaster. Heredity 91 (2003) 546-556
8. Leroi A., Bartke A., de Benedictis G., et al. What evidence is there for the existence of individual genes with antagonistic pleiotropic effects?. Mech Ageing Dev 126 (2005) 421-429
9. Zafon C. Spend less, live longer. The "thrifty aged" hypothesis. Med Hypotheses 67 (2006) 15-20
10. Sharpless N.E., and DePinho R.A. p53: Good cop/bad cop. Cell 110 (2002) 9-12
11. Kültz D. Molecular and evolutionary basis of the cellular stress response. Annu Rev Physiol 67 (2005) 225-257
12. Wahl G.M., and Carr A.M. The evolution of diverse biological responses to DNA damage: insights from yeast and p53. Nature Cell Biol 3 (2001) E277-E286
13. Sancar A., Lindsey-Boltz L., Unsal-Kacmaz K., and Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage. Annu Rev Biochem 73 (2004) 39-85
14. Fisher D. The p53 tumor suppressor: critical regulator of life and death in cancer. Apoptosis 6 (2001) 7-15
15. Vousden K., and Lu X. Live or let die: the cell's response to p53. Nature Rev Cancer 2 (2002) 594-604
16. Vousden K. Activation of the p53 tumor suppressor protein. Biochim Biophys Acta 1602 (2002) 47-59
17. Saccone C., Barome P., D'Erchia A., et al. Molecular strategies in metazoan genomic evolution. Gene 300 (2002) 195-201
18. Bálint E., and Vousden K. Activation and activities of the p53 tumour suppressor protein. Br J Cancer 85 (2001) 1813-1823
19. Afford S., and Randhawa S. Demystified: apoptosis. Mol Pathol 53 (2000) 55-63
20. Hall P. Assessing apoptosis: a critical survey. Endocr Relat Cancer 6 (1999) 3-8
21. Gastman B. Apoptosis and its clinical impact. Head Neck 23 (2001) 409-425
22. Schuler M., and Green D. Mechanisms of p53-dependent apoptosis. Biochem Soc Trans 29 (2001) 684-688
23. Donehower L.A. Does p53 affect organismal aging?. J Cell Physiol 192 (2002) 23-33
24. Fehrer C., and Lepperdinger G. Mesenchymal stem cell aging. Exp Gerontol 40 (2005) 926-930
25. van Heemst D., Mooijaart S., Beekman M., et al. Variation in the human TP53 gene affects old age survival and cancer mortality. Exp Gerontol 40 (2005) 11-15
26. Bauer J., Poon P., Glatt-Deeley H., Abrams J., and Helfand S. Neuronal expression of p53 dominant-negative proteins in adult Drosophila melanogaster extends life span. Curr Biol 15 (2005) 2063-2068
27. Varela I., Cadinanos J., Pendas A., et al. Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation. Nature 437 (2005) 564-568
28. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 37 (1965) 614-636
29. Ben-Porath I., and Weinberg R. The signals and pathways activating cellular senescence. Int J Biochem Cell Biol 37 (2005) 961-976
30. May P., and May E. Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 18 (1999) 7621-7636
31. Maier B., Gluba W., Bernier B., et al. Modulation of mammalian life span by the short isoform of p53. Genes Dev 18 (2004) 306-319
32. Ben-Porath I., and Weinberg R. When cell get stressed: an integrative view of cellular senescence. J Clin Invest 113 (2004) 8-13
33. Lynch M. How does cellular senescence prevent cancer?. DNA Cell Biol 25 (2006) 69-78
34. Gewirtz D. Growth arrest and cell death in the breast tumor cell in response to ionizing radiation and chemotherapeutic agents which induce DNA damage. Breast Cancer Res Treat 62 (2000) 223-235
35. Kahlem P., Dörken B., and Schmitt C. Cellular senescence in cancer treatment: friend or foe?. J Clin Invest 113 (2004) 169-174
36. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120 (2005) 513-522
37. Campisi J. From cells to organisms: can we learn about aging from cells in culture?. Exp Gerontol 36 (2001) 607-618
38. Krtolica A., Parrinello S., Lockectt S., Desprez P., and Campisi J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci USA 98 (2001) 12072-12077
39. Patil C., Mian I., and Campisi J. The thorny path linking cellular senescence to organismal aging. Mech Ageing Dev 126 (2005) 1040-1045
40. Magalhaes J. From cells to ageing: a review of models and mechanisms of cellular senescence and their impact on human ageing. Exp Cell Res 300 (2004) 1-10
41. Cristafolo V., Lorenzini A., Allen R., Torres C., and Tresini M. Replicative senescence: a critical review. Mech Ageing Dev 125 (2004) 827-848
42. Herbig U., Ferreira M., Condel L., Carey D., and Sedivy J. Cellular senescence in aging primates. Science 311 (2006) 1257
43. Keyes W., Wu Y., Vogel H., Guo X., Lowe S., and Mills A. p63 deficiency activates a program of cellular senescence and leads to accelerated aging. Genes Dev 19 (2005) 1986-1999
44. Trogaukus I., Saridaki A., Panayotou G., and Gonos E. Identification of differentially expressed proteins in senescent human embryonic fibroblasts. Mech Ageing Dev 127 (2006) 88-92
45. Jansen-Dürr P. Viral oncogenes as tools to study replicative senescence oh human cells. Exp Gerontol 35 (2000) 1151-1155
46. Zwerschke W., Mazurek S., Stöckl P., Hütter E., Eigenbrodt E., and Jansen-Dürr P. Metabolic analysis of senescence human fibroblasts reveals a role for AMP in cellular senescence. Biochem J 376 (2003) 403-411
47. Jones R., Plas D., Kubek S., et al. AMP-Activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 18 (2005) 283-293
48. Lin S.S., Manchester J.K., and Gordon J.I. Enhanced gluconeogenesis and increased energy storage as hallmarks of aging in Saccharomyces cerevisiae. J Biol Chem 276 (2001) 36000-36007
49. Medawar P.B. An unsolved problem in biology (1952), H.K.Lewis, London
50. Bredesen D. The non-existent aging program: how does it work?. Aging Cell 3 (2004) 255-259
51. Cichon M., and Kozlowski J. Ageing and typical survivorship curves result from optimal resource allocation. Evol Ecol Res 2 (2000) 857-870
52. Kirkwood T.B.L. Comparative life spans of species: why do species have the life spans they do?. Am J Clin Nutr 55 (1992) 1191S-1195S
53. Parsons P.A. From the stress theory of aging to energetic and evolutionary expectations for longevity. Biogerontology 4 (2003) 63-73
54. Zafon C. Ageing purpose: another thrifty genotype. Med Hypotheses 61 (2003) 482-485
55. Finch C.E. the genetics of aging. Annu Rev Genomics Hum Genet 2 (2001) 435-462
56. Tatar M., Bartke A., and Antebi A. The endocrine regulation of aging by insulin-like signals. Science 299 (2003) 1346-1351
57. Levine A., Feng Z., Mak T., You H., and Jin S. Coordination and communication between the p53 and IGF-I-AKT-TOR signal transduction pathways. Genes Dev 20 (2006) 267-275
58. Neuberg M., Buckbinder L., Seizinger B., and Kley N. The p53/IGF-1 receptor axis in the regulation of programmed cell death. Endocrine 7 (1997) 107-109
59. Butt A., Firth S., and Baxter R. The IGF axis and programmed cell death. Immunol Cell Biol 77 (1999) 256-262
60. Sonneborn J. The myth and reality of reversal of aging by hormesis. Ann NY Acad Sci 1057 (2005) 165-176